{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:32:20Z","timestamp":1760236340581,"version":"build-2065373602"},"reference-count":70,"publisher":"MDPI AG","issue":"11","license":[{"start":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T00:00:00Z","timestamp":1636848000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010942","name":"University of North Carolina at Charlotte","doi-asserted-by":"publisher","award":["Targeted Research Internal Seed Program"],"award-info":[{"award-number":["Targeted Research Internal Seed Program"]}],"id":[{"id":"10.13039\/100010942","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Non-small-cell lung cancer (NSCLC) makes up 80\u201385% of lung cancer diagnoses. Lung cancer patients undergo surgical procedures, chemotherapy, and\/or radiation. Chemotherapy and radiation can induce deleterious systemic side effects, particularly within skeletal muscle. To determine whether metformin reduces NSCLC tumor burden while maintaining skeletal muscle health, C57BL\/6J mice were injected with Lewis lung cancer (LL\/2), containing a bioluminescent reporter for in vivo tracking, into the left lung. Control and metformin (250 mg\/kg) groups received treatments twice weekly. Skeletal muscle was analyzed for changes in genes and proteins related to inflammation, muscle mass, and metabolism. The LL\/2 model effectively mimics lung cancer growth and tumor burden. The in vivo data indicate that metformin as administered was not associated with significant improvement in tumor burden in this immunocompetent NSCLC model. Additionally, metformin was not associated with significant changes in key tumor cell division and inflammation markers, or improved skeletal muscle health. Metformin treatment, while exhibiting anti-neoplastic characteristics in many cancers, appears not to be an appropriate monotherapy for NSCLC tumor growth in vivo. Future studies should pursue co-treatment modalities, with metformin as a potentially supportive drug rather than a monotherapy to mitigate cancer progression.<\/jats:p>","DOI":"10.3390\/biomedicines9111685","type":"journal-article","created":{"date-parts":[[2021,11,14]],"date-time":"2021-11-14T20:48:36Z","timestamp":1636922916000},"page":"1685","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Low-Dose Metformin as a Monotherapy Does Not Reduce Non-Small-Cell Lung Cancer Tumor Burden in Mice"],"prefix":"10.3390","volume":"9","author":[{"given":"Nicole L. Stott","family":"Bond","sequence":"first","affiliation":[{"name":"Distance Education, Technology and Integration, University of North Georgia, Dahlonega, GA 30597, USA"},{"name":"Laboratory of Systems Physiology, Department of Applied Physiology, Health, and Clinical Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7094-650X","authenticated-orcid":false,"given":"Didier","family":"Dr\u00e9au","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Marriott","sequence":"additional","affiliation":[{"name":"Department of Biological Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8487-9774","authenticated-orcid":false,"given":"Jeanette M.","family":"Bennett","sequence":"additional","affiliation":[{"name":"Department of Psychological Science, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9406-5889","authenticated-orcid":false,"given":"Michael J.","family":"Turner","sequence":"additional","affiliation":[{"name":"Laboratory of Systems Physiology, Department of Applied Physiology, Health, and Clinical Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan T.","family":"Arthur","sequence":"additional","affiliation":[{"name":"Laboratory of Systems Physiology, Department of Applied Physiology, Health, and Clinical Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6207-5986","authenticated-orcid":false,"given":"Joseph S.","family":"Marino","sequence":"additional","affiliation":[{"name":"Laboratory of Systems Physiology, Department of Applied Physiology, Health, and Clinical Sciences, University of North Carolina at Charlotte, Charlotte, NC 28223, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,11,14]]},"reference":[{"key":"ref_1","unstructured":"American Cancer Society (2019). Cancer Facts and Figures 2019, American Cancer Society. Available online: https:\/\/www.cancer.org\/content\/dam\/cancer-org\/research\/cancer-facts-and-statistics\/annual-cancer-facts-and-figures\/2019\/cancer-facts-and-figures-2019.pdf."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2913","DOI":"10.1158\/0008-5472.CAN-14-0155","article-title":"Projecting cancer incidence and deaths to 2030: The unexpected burden of thyroid, liver, and pancreas cancers in the United States","volume":"74","author":"Rahib","year":"2014","journal-title":"Cancer Res."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0025-6196(11)60735-0","article-title":"Non-small cell lung cancer: Epidemiology, risk factors, treatment, and survivorship","volume":"83","author":"Molina","year":"2008","journal-title":"Mayo Clin. Proc."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1016\/S0140-6736(16)31473-8","article-title":"New and emerging targeted treatments in advanced non-small-cell lung cancer","volume":"388","author":"Hirsch","year":"2016","journal-title":"Lancet"},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.3892\/ol.2016.4075","article-title":"Metformin: A candidate for the treatment of gynecological tumors based on drug repositioning","volume":"11","author":"Irie","year":"2016","journal-title":"Oncol. Lett."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cnur.2015.10.007","article-title":"Food and Drug Administration Drug Approval Process: A History and Overview","volume":"51","author":"Williams","year":"2016","journal-title":"Nurs. Clin. N. Am."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.phrs.2017.07.013","article-title":"Drug repurposing in cancer","volume":"124","author":"Sleire","year":"2017","journal-title":"Pharmacol. Res."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Queiroz, E.A.I.F., Puukila, S., Eichler, R., Sampaio, S.C., Forsyth, H.L., Lees, S.J., Barbosa, A.M., Dekker, R.F.H., Fortes, Z.B., and Khaper, N. (2014). Metformin Induces Apoptosis and Cell Cycle Arrest Mediated by Oxidative Stress, AMPK and FOXO3a in MCF-7 Breast Cancer Cells. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0098207"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"10269","DOI":"10.1158\/0008-5472.CAN-06-1500","article-title":"Metformin Is an AMP Kinase\u2013Dependent Growth Inhibitor for Breast Cancer Cells","volume":"66","author":"Zakikhani","year":"2006","journal-title":"Cancer Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1158\/1541-7786.MCR-16-0493","article-title":"Metformin Reduces Prostate Tumor Growth, in a Diet-Dependent Manner, by Modulating Multiple Signaling Pathways","volume":"15","author":"Gahete","year":"2017","journal-title":"Mol. Cancer Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"5196","DOI":"10.3748\/wjg.v23.i28.5196","article-title":"Sex-dependent difference in the effect of metformin on colorectal cancer-specific mortality of diabetic colorectal cancer patients","volume":"23","author":"Park","year":"2017","journal-title":"World J. Gastroenterol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/1940-6207.CAPR-13-0110","article-title":"Metformin Inhibits Skin Tumor Promotion in Overweight and Obese Mice","volume":"7","author":"Checkley","year":"2014","journal-title":"Cancer Prev. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"235","DOI":"10.3892\/br.2015.417","article-title":"Metformin and lung cancer risk of patients with type 2 diabetes mellitus: A meta-analysis","volume":"3","author":"Zhu","year":"2015","journal-title":"Biomed. Rep."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"41132","DOI":"10.18632\/oncotarget.17066","article-title":"Metformin and lung cancer risk in patients with type 2 diabetes mellitus","volume":"8","author":"Tseng","year":"2017","journal-title":"Oncotarget"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1534735419869491","DOI":"10.1177\/1534735419869491","article-title":"Metformin Prolongs Survival in Type 2 Diabetes Lung Cancer Patients With EGFR-TKIs","volume":"18","author":"Hung","year":"2019","journal-title":"Integr. Cancer Ther."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.lungcan.2014.09.012","article-title":"Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner","volume":"86","author":"Tsai","year":"2014","journal-title":"Lung Cancer"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1677\/ERC-09-0252","article-title":"Metformin blocks the stimulative effect of a high-energy diet on colon carcinoma growth in vivo and is associated with reduced expression of fatty acid synthase","volume":"17","author":"Algire","year":"2010","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"34832","DOI":"10.18632\/oncotarget.8989","article-title":"Metformin blocks progression of obesity-activated thyroid cancer in a mouse model","volume":"7","author":"Park","year":"2016","journal-title":"Oncotarget"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40880-017-0184-9","article-title":"Metformin targets multiple signaling pathways in cancer","volume":"36","author":"Lei","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"17105","DOI":"10.1038\/nrdp.2017.105","article-title":"Cancer-associated cachexia","volume":"4","author":"Baracos","year":"2018","journal-title":"Nat. Rev. Dis. Prim."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"1123S","DOI":"10.3945\/ajcn.2010.28608A","article-title":"Skeletal muscle loss: Cachexia, sarcopenia, and inactivity","volume":"91","author":"Evans","year":"2010","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1177\/1534735418781743","article-title":"Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management?","volume":"17","author":"Sorensen","year":"2018","journal-title":"Integr. Cancer Ther."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/jcsm.12376","article-title":"Muscle wasting in patients with end-stage renal disease or early-stage lung cancer: Common mechanisms at work","volume":"10","author":"Aniort","year":"2019","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Currow, D.C., Maddocks, M., Cella, D., and Muscaritoli, M. (2018). Efficacy of Anamorelin, a Novel Non-Peptide Ghrelin Analogue, in Patients with Advanced Non-Small Cell Lung Cancer (NSCLC) and Cachexia\u2014Review and Expert Opinion. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19113471"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jpainsymman.2014.09.008","article-title":"Correlation Between the International Consensus Definition of the Cancer Anorexia-Cachexia Syndrome (CACS) and Patient-Centered Outcomes in Advanced Non-Small Cell Lung Cancer","volume":"49","author":"LeBlanc","year":"2015","journal-title":"J. Pain Symptom Manag."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4251\/wjgo.v7.i4.17","article-title":"Cancer cachexia, mechanism and treatment","volume":"7","author":"Aoyagi","year":"2015","journal-title":"World J. Gastrointest. Oncol."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ajcn\/83.6.1345","article-title":"Definition of cancer cachexia: Effect of weight loss, reduced food intake, and systemic inflammation on functional status and prognosis","volume":"83","author":"Fearon","year":"2006","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/MCO.0b013e328339fdd2","article-title":"Pathogenesis of muscle wasting in cancer cachexia: Targeted anabolic and anticatabolic therapies","volume":"13","author":"Burckart","year":"2010","journal-title":"Curr. Opin. Clin. Nutr. Metab. Care"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1097\/MOG.0b013e3283347e77","article-title":"Cancer cachexia","volume":"26","author":"Tisdale","year":"2010","journal-title":"Curr. Opin. Gastroenterol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1152\/japplphysiol.00255.2006","article-title":"Metformin increases the PGC-1\u03b1 protein and oxidative enzyme activities possibly via AMPK phosphorylation in skeletal muscle in vivo","volume":"101","author":"Suwa","year":"2006","journal-title":"J. Appl. Physiol."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5980465","DOI":"10.1155\/2019\/5980465","article-title":"Metformin Delays Satellite Cell Activation and Maintains Quiescence","volume":"2019","author":"Pavlidou","year":"2019","journal-title":"Stem Cells Int."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1152\/physrev.00043.2011","article-title":"Satellite Cells and the Muscle Stem Cell Niche","volume":"93","author":"Yin","year":"2013","journal-title":"Physiol. Rev."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1530\/ERC-18-0353","article-title":"Thyroxine promotes lung cancer growth in an orthotopic mouse model","volume":"26","author":"Latteyer","year":"2019","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_35","doi-asserted-by":"crossref","unstructured":"Mordant, P., Loriot, Y., Lahon, B., Castier, Y., Les\u00e8che, G., Soria, J.-C., Vozenin, M.-C., Decraene, C., and Deutsch, E. (2011). Bioluminescent Orthotopic Mouse Models of Human Localized Non-Small Cell Lung Cancer: Feasibility and Identification of Circulating Tumour Cells. PLoS ONE, 6.","DOI":"10.1371\/journal.pone.0026073"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.biopha.2013.11.006","article-title":"Aspirin reduces lung cancer metastasis to regional lymph nodes","volume":"68","author":"Ogawa","year":"2014","journal-title":"Biomed. Pharmacother."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"479.e1","DOI":"10.1016\/j.ajog.2014.10.026","article-title":"Metformin inhibits ovarian cancer growth and increases sensitivity to paclitaxel in mouse models","volume":"212","author":"Lengyel","year":"2015","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1158\/1940-6207.CAPR-10-0055","article-title":"Metformin Prevents Tobacco Carcinogen\u2013Induced Lung Tumorigenesis","volume":"3","author":"Memmott","year":"2010","journal-title":"Cancer Prev. Res."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/nrendo.2013.256","article-title":"Metformin\u2014Mode of action and clinical implications for diabetes and cancer","volume":"10","author":"Pernicova","year":"2014","journal-title":"Nat. Rev. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1056\/NEJM199602293340906","article-title":"Metformin","volume":"334","author":"Bailey","year":"1996","journal-title":"N. Engl. J. Med."},{"key":"ref_41","doi-asserted-by":"crossref","unstructured":"Panfoli, I., Puddu, A., Bertola, N., Ravera, S., and Maggi, D. (2021). The Hormetic Effect of Metformin: \u201cLess Is More\u201d?. Int. J. Mol. Sci., 22.","DOI":"10.3390\/ijms22126297"},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.cmet.2016.03.006","article-title":"Metformin Pharmacokinetics in Mouse Tumors: Implications for Human Therapy","volume":"23","author":"Dowling","year":"2016","journal-title":"Cell Metab."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/j.jpba.2003.11.017","article-title":"Fast liquid chromatographic-tandem mass spectrometric (LC\u2013MS\u2013MS) determination of metformin in plasma samples","volume":"34","author":"Heinig","year":"2004","journal-title":"J. Pharm. Biomed. Anal."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.ajps.2019.04.002","article-title":"Engineered targeting tLyp-1 exosomes as gene therapy vectors for efficient delivery of siRNA into lung cancer cells","volume":"15","author":"Bai","year":"2020","journal-title":"Asian J. Pharm. Sci."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s11095-019-2665-9","article-title":"Targeting KRAS Mutant Lung Cancer Cells with siRNA-Loaded Bovine Serum Albumin Nanoparticles","volume":"36","author":"Mehta","year":"2019","journal-title":"Pharm. Res."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1021\/mp200394t","article-title":"Nanomedicine(s) under the microscope","volume":"8","author":"Duncan","year":"2011","journal-title":"Mol. Pharm."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"e22784","DOI":"10.1002\/jbt.22784","article-title":"Strategic targeting of non-small-cell lung cancer utilizing genetic material-based delivery platforms of nanotechnology","volume":"35","author":"Chaudhary","year":"2021","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"ref_48","first-page":"135","article-title":"Serum interleukin-6 levels in colorectal cancer patients\u2014A summary of published results","volume":"25","author":"Preiss","year":"2009","journal-title":"Int. J. Color. Dis."},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Zhao, Z., Cheng, X., Wang, Y., Han, R., Li, L., Xiang, T., He, L., Long, H., Zhu, B., and He, Y. (2014). Metformin Inhibits the IL-6-Induced Epithelial-Mesenchymal Transition and Lung Adenocarcinoma Growth and Metastasis. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0095884"},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"36441","DOI":"10.18632\/oncotarget.5541","article-title":"Metformin prevents cancer metastasis by inhibiting M2-like polarization of tumor associated macrophages","volume":"6","author":"Ding","year":"2015","journal-title":"Oncotarget"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"4921","DOI":"10.1158\/1078-0432.CCR-20-0113","article-title":"Low-Dose Metformin Reprograms the Tumor Immune Microenvironment in Human Esophageal Cancer: Results of a Phase II Clinical Trial","volume":"26","author":"Wang","year":"2020","journal-title":"Clin. Cancer Res."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"5622","DOI":"10.1158\/1078-0432.CCR-18-0420","article-title":"Metformin Inhibits Prostate Cancer Progression by Targeting Tumor-Associated Inflammatory Infiltration","volume":"24","author":"Liu","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jcsm.12232","article-title":"Mitochondrial degeneration precedes the development of muscle atrophy in progression of cancer cachexia in tumour-bearing mice","volume":"8","author":"Brown","year":"2017","journal-title":"J. Cachexia Sarcopenia Muscle"},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1002\/oby.20615","article-title":"Pro-Inflammatory macrophages increase in skeletal muscle of high fat-Fed mice and correlate with metabolic risk markers in humans","volume":"22","author":"Fink","year":"2014","journal-title":"Obesity"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.clnu.2013.06.013","article-title":"Glycine administration attenuates skeletal muscle wasting in a mouse model of cancer cachexia","volume":"33","author":"Ham","year":"2014","journal-title":"Clin. Nutr."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/JOE-12-0307","article-title":"Heterogeneous time-dependent response of adipose tissue during the development of cancer cachexia","volume":"215","author":"Batista","year":"2012","journal-title":"J. Endocrinol."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1097\/00002281-200111000-00005","article-title":"Effect of tumor necrosis factor-\u03b1 on skeletal muscle metabolism","volume":"13","author":"Li","year":"2001","journal-title":"Curr. Opin. Rheumatol."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1007\/978-981-13-1435-3_12","article-title":"NF-kB and Inflammatory Cytokine Signalling: Role in Skeletal Muscle Atrophy","volume":"1088","author":"Thoma","year":"2018","journal-title":"Adv. Exp. Med. Biol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.semcdb.2016.02.009","article-title":"STAT3 in the systemic inflammation of cancer cachexia","volume":"54","author":"Zimmers","year":"2016","journal-title":"Semin. Cell Dev. Biol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Guadagnin, E., M\u00e1zala, D., and Chen, Y.-W. (2018). STAT3 in Skeletal Muscle Function and Disorders. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19082265"},{"key":"ref_61","first-page":"15","article-title":"Nuclear magnetic resonance in conjunction with functional genomics suggests mitochondrial dysfunction in a murine model of cancer cachexia","volume":"27","author":"Constantinou","year":"2011","journal-title":"Int. J. Mol. Med."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"a011189","DOI":"10.1101\/cshperspect.a011189","article-title":"PI3K-PKB\/Akt Pathway","volume":"4","author":"Hemmings","year":"2012","journal-title":"Cold Spring Harb. Perspect. Biol."},{"key":"ref_63","doi-asserted-by":"crossref","unstructured":"Oliveira, A.G., and Gomes-Marcondes, M.C.C. (2016). Metformin treatment modulates the tumour-induced wasting effects in muscle protein metabolism minimising the cachexia in tumour-bearing rats. BMC Cancer, 16.","DOI":"10.1186\/s12885-016-2424-9"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"2893","DOI":"10.1101\/gad.1256804","article-title":"Regulation of mTOR function in response to hypoxia by REDD1 and the TSC1\/TSC2 tumor suppressor complex","volume":"18","author":"Brugarolas","year":"2004","journal-title":"Genes Dev."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"C807","DOI":"10.1152\/ajpcell.00340.2020","article-title":"Is REDD1 a metabolic double agent? Lessons from physiology and pathology","volume":"319","author":"Britto","year":"2020","journal-title":"Am. J. Physiol. Physiol."},{"key":"ref_66","first-page":"E157","article-title":"Emerging role for regulated in development and DNA damage 1 (REDD1) in the regulation of skeletal muscle metabolism","volume":"311","author":"Gordon","year":"2016","journal-title":"Am. J. Physiol. Metab."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1096\/fj.13-240580","article-title":"Skeletal muscle glycoprotein 130\u2032s role in Lewis lung carcinoma\u2013induced cachexia","volume":"28","author":"Puppa","year":"2014","journal-title":"FASEB J."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1038\/s41419-021-03932-0","article-title":"An integrative transcriptome study reveals Ddit4\/Redd1 as a key regulator of cancer cachexia in rodent models","volume":"12","author":"Niu","year":"2021","journal-title":"Cell Death Dis."},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.18632\/oncotarget.6559","article-title":"Metformin increases antitumor activity of MEK inhibitors through GLI1 downregulation in LKB1 positive human NSCLC cancer cells","volume":"7","author":"Ciaramella","year":"2016","journal-title":"Oncotarget"},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"e000132","DOI":"10.1136\/esmoopen-2016-000132","article-title":"Results of the safety run-in part of the METAL (METformin in Advanced Lung cancer) study: A multicentre, open-label phase I\u2013II study of metformin with erlotinib in second-line therapy of patients with stage IV non-small-cell lung cancer","volume":"2","author":"Morgillo","year":"2017","journal-title":"ESMO Open"}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/11\/1685\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:30:03Z","timestamp":1760167803000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/9\/11\/1685"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,14]]},"references-count":70,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["biomedicines9111685"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines9111685","relation":{},"ISSN":["2227-9059"],"issn-type":[{"type":"electronic","value":"2227-9059"}],"subject":[],"published":{"date-parts":[[2021,11,14]]}}}